Lanean...
Rapid identification and evaluation of neoantigen-reactive T cell receptors from single cells.
Engineered T cells expressing tumor-specific T cell receptors (TCRs) are emerging as a mode of personalized cancer immunotherapy that requires identification of TCRs against the products of known driver mutations and novel mutations in a timely fashion. We present a non-viral and non-next generation...
Gorde:
| Argitaratua izan da: | J Immunother |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7725897/ https://ncbi.nlm.nih.gov/pubmed/33086340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000342 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|